International experts issue first guidance on caring for critically-ill COVID-19 patients

Health Industry Hub | March 25, 2020 |
[Total: 1    Average: 5/5]

Medical News: Australian experts along with their international colleagues have issued the first guidelines for what works and what doesn’t in treating critically-ill COVID-19 patients in intensive care. The guidelines also detail precautions which medical staff need to take to avoid being infected themselves.

Intensive Care Units are at the frontline of the struggle against coronavirus. Now doctors have issued the first guidance on what works and what doesn’t in treating critically-ill COVID-19 patients in intensive care. This new guidance, developed by international experts from the European Society of Intensive Care Medicine, also details precautions which medical staff need to take to avoid being infected themselves.

The George Institute for Global Health and UNSW Sydney, and Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, were involved in the development of the guidance.

HCP engagement during COVID-19. Health Industry Hub combines expertise in target audience insights, delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry.

ESICM President-Elect, Maurizio Cecconi (from Humanitas University, Milan, Italy), saidMany patients with COVID-19 suffer from acute respiratory failure, requiring invasive mechanical ventilation in Intensive Care Units (ICU). Italy, the most affected Western Country, reports that 12% of all coronavirus positive patients are critically ill and require ICU treatment. ICUs are under huge pressure and intensive care specialists all over the World are working to increase ICU capacity and provide high quality care.

This is the first guidance to lay out what works and what doesn’t in treating coronavirus-infected patients in intensive care. It’s based on decades of research on acute respiratory infection being applied to COVID-19 patients. We make 50 recommendations, with the most important ones relating to the need to ventilate the patients. These are people who have lungs which are failing through pneumonia caused by the coronavirus, and we need to help them through. Giving them oxygen in a “protective lung strategy” can buy them time”.

The guidance is aimed at hospital clinicians managing critically ill adults with COVID-19 in the intensive care unit. The target users of this guideline are frontline clinicians, allied health professionals, and policymakers involved in the care of patients with COVID-19 in the ICU. It is internationally relevant.

Professor Cecconi continued, “There is no specific cure for this virus, all we can do is nurse people through the worst of the infection, and give them time to recover. It is also important that Governments put in place public health measures to try to slow down the infection rate; this is necessary to avoid ICUs being overwhelmed. This is a disease which didn’t exist just a few months ago, so we need to review all possible evidence to ensure that clinicians can use what actually works. We need to make sure that doctors are aware of which treatments are useful and appropriate”.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

Intensive Care doctors are bearing the brunt of the struggle against COVID-19, with ICUs either near capacity or overflowing in many countries. In Italy, which is at the frontline of the epidemic in the West, almost 9% of positive coronavirus cases are health workers. This means that they themselves have to stop work to avoid passing on the virus.

Professor Cecconi added “At the same time as caring for patients, we need to make sure that health workers are following procedures which will allow themselves to be protected against infection. We must protect them, they are in the front line. We cannot allow our healthcare workers to be at risk. On top of that, if they get infected they could also spread the disease further. This is also addressed in the guideline”.

The new guidance is issued by the European Society of Intensive Care Medicine (ESICM), and the Society of Critical Care Medicine (SCCM) under the umbrella of the joint project Surviving Sepsis Campaign (SSC). ESICM represents around 9000 intensive care clinicians in Europe and internationally.  The Guidelines convened a panel of 36 experts from 12 countries including Australia, to respond to questions relevant to the treatment of COVID-19 in intensive care. It was published on 24 March in the peer-reviewed journal Intensive Care Medicine.

“COVID-19 cases are rising rapidly worldwide, and so we are increasingly seeing that Intensive Care Units have difficulty in dealing with the tide of patients. We need more resource in ICUs, and quickly. This means more ventilators and more trained personnel. In the meantime, this guidance aims to rationalise our approach and to avoid unproven strategies.” said Professor Giuseppe Citerio (University of Milano-Bicocca, Editor in Chief of Intensive Care Medicine).

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

Pharma News - 20 biopharmaceutical companies enter a ground-breaking partnership - AMR Action Fund

20 biopharmaceutical companies enter a ground-breaking partnership

Health Industry Hub | July 10, 2020 |

Please log in to Health Industry Hub to view this content in the ‘News & Trends’ menu.

Health Industry Hub is Australia’s ONLY one-stop-hub connecting Pharma, Biotech and MedTech industry professionals. Learn more.


Market Research & Insights

Market Research Pharma Biotech MedTech - Incredible breadth of Australia’s COVID-19 research: From vaccines to aircon filters

Incredible breadth of Australia’s COVID-19 research: From vaccines to aircon filters

Health Industry Hub | July 9, 2020 |

Market Research & Insights: Since the coronavirus hit Australia’s shores, health and medical researchers have been rapidly redeployed in unprecedented […]



Pharma Biotech Medtech Mentoring - Award-winning IMNIS program fosters collaboration and innovation between industry and academia

Award-winning IMNIS program fosters collaboration and innovation between industry and academia

Health Industry Hub | July 9, 2020 |

Mentoring: The Industry Mentoring Network in STEM (IMNIS) provides PhD student mentees an understanding of the industry sector, strengthen their […]



Communication Public Relations Pharma Biotech Medtech - The changing landscape of Pharma corporate communications - interview

The changing landscape of corporate communications in the Pharma industry

Health Industry Hub | July 8, 2020 |

COVID-19 has had a dramatic impact on the role and nature of healthcare communications, especially following the recent bushfire crisis […]